Harbor Capital Advisors Inc. Sells 38,181 Shares of Perrigo Company plc $PRGO

Harbor Capital Advisors Inc. cut its stake in shares of Perrigo Company plc (NYSE:PRGO) by 66.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 19,444 shares of the company’s stock after selling 38,181 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in Perrigo were worth $433,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of PRGO. Millennium Management LLC grew its stake in Perrigo by 5,198.0% in the first quarter. Millennium Management LLC now owns 2,052,599 shares of the company’s stock worth $57,555,000 after purchasing an additional 2,013,856 shares in the last quarter. Norges Bank purchased a new stake in shares of Perrigo in the 2nd quarter worth $36,755,000. Perpetual Ltd grew its position in shares of Perrigo by 64.2% during the 3rd quarter. Perpetual Ltd now owns 3,149,878 shares of the company’s stock worth $70,148,000 after buying an additional 1,231,400 shares in the last quarter. Ion Asset Management Ltd. increased its stake in shares of Perrigo by 34.7% during the second quarter. Ion Asset Management Ltd. now owns 3,817,621 shares of the company’s stock valued at $102,007,000 after buying an additional 983,727 shares during the period. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Perrigo by 126.6% in the first quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company’s stock valued at $32,520,000 after acquiring an additional 647,982 shares in the last quarter. Hedge funds and other institutional investors own 95.91% of the company’s stock.

Insider Transactions at Perrigo

In other Perrigo news, Director Geoffrey M. Parker purchased 7,500 shares of the firm’s stock in a transaction on Wednesday, November 12th. The stock was bought at an average cost of $14.18 per share, for a total transaction of $106,350.00. Following the completion of the purchase, the director owned 17,375 shares in the company, valued at $246,377.50. This represents a 75.95% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.40% of the stock is owned by corporate insiders.

Perrigo Stock Up 0.5%

Shares of Perrigo stock opened at $13.83 on Monday. The company has a quick ratio of 1.44, a current ratio of 2.51 and a debt-to-equity ratio of 0.81. The company has a market cap of $1.90 billion, a P/E ratio of -36.38 and a beta of 0.39. The firm’s 50 day moving average price is $15.39 and its 200-day moving average price is $21.23. Perrigo Company plc has a 52-week low of $12.17 and a 52-week high of $30.93.

Perrigo (NYSE:PRGO) last announced its earnings results on Wednesday, November 5th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.75 by $0.05. Perrigo had a negative net margin of 1.21% and a positive return on equity of 9.16%. The company had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period last year, the firm earned $0.81 earnings per share. Perrigo’s revenue was down 4.1% compared to the same quarter last year. Perrigo has set its FY 2025 guidance at 2.700-2.80 EPS. On average, sell-side analysts predict that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Friday, November 28th were paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 8.4%. The ex-dividend date was Friday, November 28th. Perrigo’s payout ratio is -305.26%.

Analyst Upgrades and Downgrades

PRGO has been the topic of several recent research reports. Wall Street Zen cut shares of Perrigo from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Jefferies Financial Group dropped their price objective on shares of Perrigo from $27.00 to $23.00 and set a “hold” rating on the stock in a research note on Monday, October 27th. JPMorgan Chase & Co. cut their price objective on shares of Perrigo from $20.00 to $18.00 and set a “neutral” rating on the stock in a report on Monday, December 15th. Zacks Research lowered Perrigo from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. Finally, Canaccord Genuity Group dropped their target price on Perrigo from $40.00 to $20.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Perrigo presently has an average rating of “Reduce” and a consensus price target of $22.00.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.